2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow ALL: new trials by email Literature Review of ALL trials Research Report on ALL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia Prednisone, Vincristine, Daunorubicin - ALL | Phase 2 | Unknown | PETHEMA Foundation | 30 | 2016-06-01 | 2022-02-18 |
| Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) fludarabine phosphate, busulfan - AML, MDS | Phase 2 | Unknown | Samsung Medical Center | 114 | 2008-08-01 | 2008-12-30 |
Lymphoma (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Busulfan (1) · Cytarabine (1) · Daunorubicin (1) · Etoposide (1) · Mercaptopurine (1) · Methotrexate (1) · Prednisone (1) · Transplantation, Autologous (1) · Vincristine (1) · fludarabine (1) · fludarabine phosphate (1) · ponatinib (1)
PETHEMA Foundation (1) · Samsung Medical Center (1)
South Korea (1) · Spain (1)
Dong Hwan Kim (1)